登录

Ewell Technology Acquires 18% equity of Yijie Medical in A Deal Worth ¥54M

作者: Mailman 2020-02-11 17:33
思创医惠科技
http://www.sichuangyihui.com.cn/
企业数据由 动脉橙 提供支持
智慧医疗和物联网应用整体解决方案供应商 | IPO | 运营中
中国-浙江
2010-04-30
融资金额:RMB¥9.86亿
查看

According to PEdaily.cn, Ewell Technology has announced the acquirement of 18% equity of Hangzhou Yijie Medical Device Co., Ltd. ("Yijie Medical") from Ningbo Huirui Investment in a deal worth 54 million yuan. Upon completion of the transfer, Ewell will hold an 18% stake in Yijie Medical.


This acquisition is based on the goal to accelerate Ewell Technology's layout in the field of the Internet of Medical Things (IoMT) and the implementation of the IoMT traceability management project. 


The IoMT traceability management project is one of the 2018 non-public stock offering investment projects of Ewell Technology, based on RFID technology and an open platform of IoMT. The project uses the IoMT technology to realize automatic identification, positioning, monitoring and management of medical cleaning supplies. It provides the hospital with closed-loop management services.


Yijie Medical is a high-tech enterprise specializing in the development and production of smart medical equipment. The intelligent management recovery vehicle for bedding and clothing and other products of Yijie Medical can provide hardware support for the IoMT traceability management project.


Ewell Technology has developed its own medical information open platform, combining with the mobile Internet and the Internet of things, delivering information from families, community, to the hospital. It also uses big data and deep learning and cognitive computing and other advanced technology to provide digital medical and artificial intelligence services. The company is committed to protecting patients' safety, improving the efficiency of clinical, and optimizing the allocation of medical resources.


By taking advantage of the products and technology of Yijie Medical, Ewell Technology can further explore the whole process management market of medical materials and devices.

注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

《2022数字医疗年度创新白皮书》发布,三大领域五大热点全面讲述数字医疗“中国故事”

与火山引擎深化内容合作,方舟健客如何做好创新患者慢病服务?

风再起时,如何应对数字医疗新一轮浪潮?

【首发】优脑银河完成上亿元Pre-A轮融资,加速推动脑疾病精准诊疗

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

全病种皮肤AI系统问世,皮肤病患者可在家中自测

2020-02-11
下一篇

Advaccine Snags ¥30M from Penyao E.P.

2020-02-11